| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,127 |
1,042 |
$95K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
720 |
666 |
$36K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
504 |
474 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
416 |
397 |
$9K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
183 |
173 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
669 |
640 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
112 |
108 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
15 |
15 |
$682.14 |
| 87634 |
|
14 |
12 |
$649.32 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$615.72 |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$612.00 |
| 99051 |
|
100 |
95 |
$245.56 |
| 94760 |
|
53 |
50 |
$158.60 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$27.30 |
| 99080 |
|
16 |
16 |
$0.00 |
| 99000 |
|
43 |
43 |
$0.00 |